See more : Marathon Oil Corporation (0JY9.L) Income Statement Analysis – Financial Results
Complete financial analysis of Aju IB Investment Co., Ltd. (027360.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aju IB Investment Co., Ltd., a leading company in the Investment – Banking & Investment Services industry within the Financial Services sector.
- Gores Holdings VIII, Inc. (GIIXU) Income Statement Analysis – Financial Results
- Zhejiang Asia-Pacific Mechanical & Electronic Co.,Ltd (002284.SZ) Income Statement Analysis – Financial Results
- Lottery.com Inc. (LTRY) Income Statement Analysis – Financial Results
- CNOOC Energy Technology & Services Limited (600968.SS) Income Statement Analysis – Financial Results
- GSE Systems, Inc. (GVP) Income Statement Analysis – Financial Results
Aju IB Investment Co., Ltd. (027360.KQ)
Industry: Investment - Banking & Investment Services
Sector: Financial Services
Website: http://www.ajuib.co.kr
About Aju IB Investment Co., Ltd.
Aju IB Investment Co., Ltd. is a venture capital and private equity arm of AJU Corporation Co., Ltd. It specializes in mezzanine, buyouts, corporate restructuring, and all stages of venture investments in small to medium sized start-up companies in South Korea. The firm considers investments in information technology including mobile service platforms, software, semiconductor, contents, biotechnology, life science, and environment sectors. For venture capital investments, it focuses on high technology sector and for private equity investments, the firm focuses on manufacturing sector. It typically invests in South Korea but also makes investments in other countries. The firm also considers investments in companies with main business in immune system platform technology, oncology drugs, and ophthalmic drugs. It also invests in information communication technology including Internet of Things, artificial intelligence, smart car, and advanced materials. The firm considers investments in companies that have been evaluated by technology credit bureaus or in companies with ratings of T5 and above, which is provided by technology credit bureaus. For the investments by the office in Boston, Massachusetts, the firm primarily invests in therapeutics serving large unmet medical need; enabling platform technologies with maturing lead candidate; potential for partnership or alliance with Korean pharmaceutical companies; other areas of interest are medical devices & diagnostics. It prefers to invest between $0.87 million to $2.61 million for venture capital investments and $4.36 million to $17.45 million for private equity investments. The firm typically exits through IPO and mergers and acquisitions. Aju IB Investment Co., Ltd., formerly known as Kibo Technology Advancing Capital Co., was founded in 1974 and is based in Seoul, South Korea with an additional office in Boston, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 53.74B | 23.80B | 59.38B | 34.44B | 35.22B | 18.57B | 31.46B | 65.47B | 60.23B | 74.20B | 50.59B | 22.62B |
| Cost of Revenue | 1.75B | 12.71B | 8.38B | 41.28B | 8.55B | 407.87M | 757.15M | 827.35M | 791.70M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 52.00B | 11.08B | 51.01B | -6.84B | 26.67B | 18.16B | 30.71B | 64.64B | 59.44B | 74.20B | 50.59B | 22.62B |
| Gross Profit Ratio | 96.75% | 46.58% | 85.90% | -19.87% | 75.72% | 97.80% | 97.59% | 98.74% | 98.69% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | -0.10 | 0.50 | 0.81 | 0.55 | 0.78 | 0.51 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.24B | 1.33B | 1.06B | 910.17M | 367.17M | 335.81M | 227.82M | 197.76M | 210.16M | 210.84M | 210.33M | 227.11M |
| Selling & Marketing | 1.70B | 1.53B | 1.60B | 1.15B | 53.20M | 61.10M | 19.50M | 20.21M | 16.60M | 21.32M | 29.75M | 38.98M |
| SG&A | 2.94B | 2.87B | 2.66B | 2.06B | 8.74B | 0.63 | 0.41 | 0.19 | 8.07B | 7.75B | 6.84B | 6.46B |
| Other Expenses | 0.00 | -11.84B | -20.20B | 36.15B | -5.63B | 2.85B | 5.20B | -37.87B | 9.16B | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 10.43B | 11.84B | 20.20B | -36.15B | 5.63B | 44.97B | 31.39B | 46.89B | -9.16B | 62.08B | 42.44B | 28.79B |
| Cost & Expenses | 10.43B | 24.56B | 28.57B | 5.13B | 14.18B | 44.97B | 31.39B | 46.89B | 49.14B | 62.08B | 42.44B | 28.79B |
| Interest Income | 2.21B | 1.51B | 739.97M | 648.09M | 1.11B | 1.12B | 4.18B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.66B | 1.31B | 1.29B | 1.35B | 1.47B | 1.73B | 1.65B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.95B | 24.56B | 28.57B | 5.13B | 14.18B | 7.23B | 21.96B | 55.58B | 354.99M | -56.00B | -33.10B | -5.23B |
| EBITDA | 23.46B | 910.27M | 32.18B | 30.05B | 21.18B | 11.43B | 9.84B | -31.08B | 11.45B | -43.88B | -24.96B | -10.67B |
| EBITDA Ratio | 43.65% | 3.82% | 54.20% | 87.24% | 60.13% | -181.35% | -45.86% | -47.48% | 114.49% | -59.13% | -49.34% | -47.18% |
| Operating Income | 43.31B | -757.65M | 30.81B | 29.31B | 21.04B | 100.97M | 337.45M | 348.75M | 68.60B | 56.00B | 33.10B | 5.23B |
| Operating Income Ratio | 80.58% | -3.18% | 51.88% | 85.10% | 59.72% | 0.54% | 1.07% | 0.53% | 113.90% | 75.46% | 65.44% | 23.11% |
| Total Other Income/Expenses | -25.56B | -1.63B | -1.13B | 33.64B | 521.56M | 3.23B | 24.40M | -1.51B | -62.91B | -54.33B | -24.96B | -11.40B |
| Income Before Tax | 17.75B | -2.39B | 29.68B | 27.77B | 19.42B | 11.82B | 11.25B | 53.31B | 14.19B | 12.12B | 8.14B | -6.17B |
| Income Before Tax Ratio | 33.03% | -10.05% | 49.98% | 80.63% | 55.14% | 63.64% | 35.75% | 81.42% | 23.56% | 16.33% | 16.09% | -27.27% |
| Income Tax Expense | 1.15B | 2.49B | 12.84B | 13.51B | 5.27B | 11.71B | 10.91B | 52.96B | 2.51B | 2.49B | 1.62B | 361.95M |
| Net Income | 16.60B | 2.04B | 39.33B | 49.44B | 16.29B | 14.56B | 16.11B | 15.09B | 11.68B | 9.63B | 6.52B | -5.81B |
| Net Income Ratio | 30.89% | 8.57% | 66.24% | 143.55% | 46.24% | 78.44% | 51.21% | 23.04% | 19.39% | 12.97% | 12.90% | -25.67% |
| EPS | 141.00 | 17.29 | 339.37 | 429.31 | 137.34 | 135.58M | 30.12M | 29.35M | 478.69 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 140.07 | 3.11 | 339.37 | 429.31 | 137.34 | 135.58M | 30.12M | 29.35M | 478.69 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 117.74M | 117.94M | 115.90M | 115.16M | 118.60M | 107.41 | 535.00 | 514.00 | 24.40M | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out (Dil) | 118.53M | 119.91M | 115.90M | 115.16M | 118.60M | 107.41 | 535.00 | 514.00 | 24.40M | 0.00 | 0.00 | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports